Volume 7 Issue 205
Published - 14:00 UTC 08:00 EST 24-Jul-2005 
Next Update - 14:00 UTC 08:00 EST 25-Jul-2005

Editor: Susan K. Boyer, RN
© Vidyya.
All rights reserved.

We subscribe to the HONcode principles. Verify here.

  

 


FDA approved Rozerem™ (ramelteon)

Takeda Pharmaceuticals North America, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for RozeremTM (ramelteon) 8-mg tablets for the treatment of insomnia characterized by difficulty with sleep onset. The FDA approval allows physicians to prescribe Rozerem for long-term use in adults. more  

Prescribing information: Rozerem (ramelteon) tablets

Rozerem is indicated for the treatment of insomnia characterized by difficulty with sleep onset. Rozerem should not be used in patients with hypersensitivity to ramelteon or any components of the formulation. Rozerem can be prescribed for long-term use. However, failure of insomnia to remit after a reasonable period of time, worsening of insomnia, or the emergence of new cognitive or behavioral abnormalities after taking Rozerem should be evaluated, as such symptoms may be the result of an unrecognized underlying medical disorder. more

Statin therapy may lower mortality in heart failure patients

Cholesterol-lowering statin therapy may improve survival in patients with diastolic heart failure (DHF) according to a paper published in Circulation: Journal of the American Heart Association by cardiologists at Wake Forest University Baptist Medical Center. more  

Gene’s mutations found to cause life-threatening aortic disease

Scientists have identified the first genetic mutations that cause the aorta – the body's main artery – to widen, tear and rupture. more

Scientists discover that three molecules may be developed into new Alzheimer's drugs 

A team of scientists has discovered three molecules –– from a search of 58,000 compounds –– that appear to inhibit a key perpetrator of Alzheimer's disease. more

Minimally invasive solid tumor biopsy may replace surgery to get diagnostic specimens  

Inserting biopsy needles through the skin appears to be a safe and reliable alternative to surgery for obtaining diagnostic samples of a suspected solid tumor in children, according to results of a study by investigators at St. Jude Children's Research Hospital. The technique, called percutaneous ("through the skin") core-needle biopsy, provides samples of tissue suitable for accurate initial diagnosis of a solid tumor, the researchers say. more

Nuclear weapons continue to pose a serious health risk in Europe

Nuclear weapons in various European countries, particularly Russia, pose a serious threat to health, argues a letter in this week's BMJ. more

 

Nuclear weapons continue to pose a serious health risk in Europe